Historical shareholding details of DFA US Targeted Value Portfolio holdings in CRISPR Therapeutics AG (CRSP)

Monthly changes of DFA US Targeted Value Portfolio shareholding in CRISPR Therapeutics AG over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Dfa Us Targeted Value Portfolio 11,590 0.01%
Dec 31, 2024 Dfa Us Targeted Value Portfolio 11,590 0.01%

View all ownership details of CRISPR Therapeutics AG